These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25908591)

  • 1. PET after chemotherapy identifies Hodgkin's lymphoma patients who can avoid radiotherapy.
    Mayor S
    BMJ; 2015 Apr; 350():h2190. PubMed ID: 25908591
    [No Abstract]   [Full Text] [Related]  

  • 2. PET-Directed Therapy for Hodgkin's Lymphoma.
    Bishop G
    N Engl J Med; 2015 Jul; 373(4):392. PubMed ID: 26200988
    [No Abstract]   [Full Text] [Related]  

  • 3. PET-Directed Therapy for Hodgkin's Lymphoma.
    Radford J; Illidge T; Barrington S
    N Engl J Med; 2015 Jul; 373(4):392. PubMed ID: 26200987
    [No Abstract]   [Full Text] [Related]  

  • 4. Personalised approach to treating early Hodgkin's lymphoma.
    Illidge T
    BMJ; 2015 Jun; 350():h2927. PubMed ID: 26038281
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.
    Engert A; Haverkamp H; Kobe C; Markova J; Renner C; Ho A; Zijlstra J; Král Z; Fuchs M; Hallek M; Kanz L; Döhner H; Dörken B; Engel N; Topp M; Klutmann S; Amthauer H; Bockisch A; Kluge R; Kratochwil C; Schober O; Greil R; Andreesen R; Kneba M; Pfreundschuh M; Stein H; Eich HT; Müller RP; Dietlein M; Borchmann P; Diehl V; ; ;
    Lancet; 2012 May; 379(9828):1791-9. PubMed ID: 22480758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversies in the treatment of early-stage Hodgkin's lymphoma.
    Longo DL; Armitage JO
    N Engl J Med; 2015 Apr; 372(17):1667-9. PubMed ID: 25901431
    [No Abstract]   [Full Text] [Related]  

  • 7. Escalated BEACOPP in advanced Hodgkin's lymphoma.
    Casasnovas O; Coiffier B
    Lancet; 2012 May; 379(9828):1767-8. PubMed ID: 22480757
    [No Abstract]   [Full Text] [Related]  

  • 8. PET-adapted salvage therapy for Hodgkin's lymphoma.
    Laffon E; Marthan R
    Lancet Oncol; 2015 May; 16(5):e197-8. PubMed ID: 25943059
    [No Abstract]   [Full Text] [Related]  

  • 9. PET-adapted salvage therapy in Hodgkin's lymphoma.
    Tirelli U; Spina M
    Lancet Oncol; 2015 Mar; 16(3):239-40. PubMed ID: 25683849
    [No Abstract]   [Full Text] [Related]  

  • 10. PET-adapted salvage therapy for Hodgkin's lymphoma--authors' reply.
    Schöder H; Moskowitz CH; Moskowitz AJ
    Lancet Oncol; 2015 May; 16(5):e198. PubMed ID: 25943060
    [No Abstract]   [Full Text] [Related]  

  • 11. Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy. In Reply to Adams and Kwee.
    Simontacchi G; Filippi AR; Ciammella P; Ricardi U
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):725-6. PubMed ID: 26461018
    [No Abstract]   [Full Text] [Related]  

  • 12. Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy. In Regard to Simontacchi et al.
    Adams HJ; Kwee TC
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):724-5. PubMed ID: 26461017
    [No Abstract]   [Full Text] [Related]  

  • 13. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
    Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
    Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omitting radiotherapy after attaining FDG PET-negative status following chemotherapy alone for Hodgkin lymphoma: a randomized study caveat.
    Yahalom J
    Leuk Lymphoma; 2007 Sep; 48(9):1667-9. PubMed ID: 17786699
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma.
    Kobe C; Kuhnert G; Kahraman D; Haverkamp H; Eich HT; Franke M; Persigehl T; Klutmann S; Amthauer H; Bockisch A; Kluge R; Wolf HH; Maintz D; Fuchs M; Borchmann P; Diehl V; Drzezga A; Engert A; Dietlein M
    J Clin Oncol; 2014 Jun; 32(17):1776-81. PubMed ID: 24799482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.
    Agostinelli C; Gallamini A; Stracqualursi L; Agati P; Tripodo C; Fuligni F; Sista MT; Fanti S; Biggi A; Vitolo U; Rigacci L; Merli F; Patti C; Romano A; Levis A; Trentin L; Stelitano C; Borra A; Piccaluga PP; Hamilton-Dutoit S; Kamper P; Zaucha JM; Małkowski B; Kulikowski W; Tajer J; Subocz E; Rybka J; Steidl C; Broccoli A; Argnani L; Gascoyne RD; d'Amore F; Zinzani PL; Pileri SA
    Lancet Haematol; 2016 Oct; 3(10):e467-e479. PubMed ID: 27692305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-stage favorable Hodgkin's lymphoma: is chemotherapy alone sufficient?
    Ozsahin M; Ozsahin H
    J Clin Oncol; 2010 Nov; 28(32):e668-9; author reply e670. PubMed ID: 20713868
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy and radiotherapy in Hodgkin's lymphoma: joining in or splitting up?
    van der Maazen RW; Raemaekers JM
    Curr Opin Oncol; 2006 Nov; 18(6):660-6. PubMed ID: 16988591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Benefit of Involved-Field Radiotherapy for Patients With Relapsed-Refractory Hodgkin's Lymphoma With Incomplete Response Before Autologous Stem Cell Transplantation.
    Levis M; Piva C; Filippi AR; Botto B; Gavarotti P; Pregno P; Nicolosi M; Freilone R; Parvis G; Gottardi D; Vitolo U; Ricardi U
    Clin Lymphoma Myeloma Leuk; 2017 Jan; 17(1):14-22. PubMed ID: 27727134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine-Tuning the Treatment of Hodgkin's Lymphoma.
    Bartlett NL
    N Engl J Med; 2016 Jun; 374(25):2490-2. PubMed ID: 27332908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.